AKT1 and melanoma: Recently, it has been demonstrated that evodiamine, a novel alkaloid isolated from the fruit of tetradium, significantly inhibits the growth of vemurafenib-resistant melanoma cells by inhibiting the PI3K/Akt signaling pathway through the suppression of IRS4 (insulin receptor substrate 4) [364].